These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 803799)
41. [Prevention and treatment of cardiac arrhythmias with rhythmodan (disopyramide)]. Doshchitsin VL; Golovina TN; Osipova TN Kardiologiia; 1973 Mar; 13(3):97-101. PubMed ID: 4780484 [No Abstract] [Full Text] [Related]
42. [Anti-arrhythmia effect of disopyramide]. Olbermann M; Just H; Guckenbiehl H; Lang KF Verh Dtsch Ges Inn Med; 1975; 81():152-5. PubMed ID: 1229482 [No Abstract] [Full Text] [Related]
43. [Disopyramide in the therapy and prevention of chronic atrial fibrillation. Study of 50 cases]. Pellegrino L; Prencipe D Minerva Cardioangiol; 1973 Dec; 21(12):827-32. PubMed ID: 4780271 [No Abstract] [Full Text] [Related]
44. Disopyramide in the prevention of recurrence of atrial fibrillation after electroconversion. Härtel G; Louhija A; Konttinen A Clin Pharmacol Ther; 1974 Jun; 15(6):551-5. PubMed ID: 4601741 [No Abstract] [Full Text] [Related]
45. [Disopyramide in the therapy and prevention of chronic atrial fibrillation. Study of 50 cases]. Pellegrino L; Prencipe D Usp Sovrem Biol; 1973; 76(4):827-32. PubMed ID: 4793143 [No Abstract] [Full Text] [Related]
46. The clinical scope of disopyramide seven years after introduction--an overview. Willis PW Angiology; 1987 Feb; 38(2 Pt 2):165-73. PubMed ID: 2435196 [TBL] [Abstract][Full Text] [Related]
47. Drugs for cardiac arrhythmias. Treat Guidel Med Lett; 2007 Jun; 5(58):51-8. PubMed ID: 17505408 [No Abstract] [Full Text] [Related]
49. Congestive heart failure caused by oral disopyramide. Podrid PJ; Schoeneberger A; Lown B N Engl J Med; 1980 Mar; 302(11):614-7. PubMed ID: 7351909 [No Abstract] [Full Text] [Related]
50. [Cardiac arrhythmia and its therapy]. Mürtz R; Veltmann G; Jorde R; Begenat H Med Monatsschr; 1970 Jun; 24(6):239-45. PubMed ID: 5525110 [No Abstract] [Full Text] [Related]
51. Disopyramide for arrhythmias. Drug Ther Bull; 1977 Sep; 15(19):75-6. PubMed ID: 913246 [No Abstract] [Full Text] [Related]
52. [Clinical pharmacology of disopyramide]. Rewerski W; Dorociak A; Walczak F; Dobiasz A Pol Tyg Lek; 1980 Jul; 35(29):1109-12. PubMed ID: 7001399 [No Abstract] [Full Text] [Related]
53. Clinical evaluation of antiarrhythmic effects of disopyramide by multiclinical controlled double-blind methods. Kimura E; Mashima S; Tanaka T Int J Clin Pharmacol Ther Toxicol; 1980; 18(8):338-43. PubMed ID: 7409935 [TBL] [Abstract][Full Text] [Related]
54. Acute termination of cardiac arrhythmias with intravenous disopyramide. Mizgala HF; Huvelle PR J Int Med Res; 1976; 4(1 Suppl):82-5. PubMed ID: 1026535 [No Abstract] [Full Text] [Related]
55. [First experience on the use of disopyramide]. de Oliveira JM Hospital (Rio J); 1970 Jan; 77(1):35-55. PubMed ID: 5310003 [No Abstract] [Full Text] [Related]
58. Long-term use of controlled-release disopyramide in patients with severe ventricular arrhythmias. Paulk EA Angiology; 1987 Feb; 38(2 Pt 2):198-204. PubMed ID: 3103494 [TBL] [Abstract][Full Text] [Related]